Healthcare provider profile · identity verified

Barbara Richards, FNP

Nurse Practitioner · DUBLIN, OH · NPI 1265829105

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	229	28
Mirtazapine	Mirtazapine	186	35
Sertraline Hcl	Sertraline Hcl	180	31
Furosemide	Furosemide	174	26
Gabapentin	Gabapentin	130	19
Buspirone Hcl	Buspirone Hcl	122	25
Potassium Chloride	Potassium Chloride	119	25
Ondansetron Hcl	Ondansetron Hcl	114	54
Eliquis	Apixaban	112	12
Amlodipine Besylate	Amlodipine Besylate	106	14
Atorvastatin Calcium	Atorvastatin Calcium	103	22
Metoprolol Tartrate	Metoprolol Tartrate	98	14
Trazodone Hcl	Trazodone Hcl	98	18
Pantoprazole Sodium	Pantoprazole Sodium	97	17
Nystatin	Nystatin	94	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	88	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	74	26
Jardiance	Empagliflozin	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	57	suppressed
Allopurinol	Allopurinol	54	suppressed
Metoprolol Succinate	Metoprolol Succinate	54	suppressed
Fluconazole	Fluconazole	47	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Lisinopril	Lisinopril	45	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Lactulose	Lactulose	41	suppressed
Olanzapine	Olanzapine	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Lorazepam	Lorazepam	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Cephalexin	Cephalexin	33	19
Alprazolam	Alprazolam	31	12
Metformin Hcl	Metformin Hcl	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	15
Albuterol Sulfate	Albuterol Sulfate	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Losartan Potassium	Losartan Potassium	23	suppressed
Baclofen	Baclofen	22	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Lithium Carbonate	Lithium Carbonate	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Bydureon Bcise	Exenatide Microspheres	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Cimetidine	Cimetidine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Torsemide	Torsemide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Lidocaine	Lidocaine	13	suppressed
Metolazone	Metolazone	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Enulose	Lactulose	12	suppressed
Finasteride	Finasteride	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Primidone	Primidone	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error